Norimoto Gotoh

Title: Norimoto Gotoh: Innovator in Ocular Drug Delivery

Introduction

Norimoto Gotoh is a prominent inventor based in Fujinomiya, Japan. He is known for his innovative contributions to the field of ocular drug delivery systems. His work focuses on developing novel methods to enhance the delivery of drugs to the posterior segment of the eye.

Latest Patents

Norimoto Gotoh holds a patent for a "Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion." The purpose of this invention is to provide a novel system for the delivery of a drug to the posterior segment of the eye. This invention relates to a cytophilic peptide-fused high-density lipoprotein (cHDL) that can be used as a carrier for drug delivery. It also includes a method for producing the cHDL, a pharmaceutical composition, and a system for diagnosing, preventing, or treating posterior ocular diseases.

Career Highlights

Throughout his career, Norimoto Gotoh has made significant strides in the field of biomedical research. He has worked with esteemed institutions, including Kyoto University, where he contributed to various research projects. His innovative approach has led to advancements in drug delivery systems, particularly for ocular applications.

Collaborations

Norimoto Gotoh has collaborated with notable colleagues, including Kenji Suda and Tatsuya Murakami. These collaborations have further enriched his research and contributed to the development of effective drug delivery systems.

Conclusion

Norimoto Gotoh's work in ocular drug delivery represents a significant advancement in medical technology. His innovative patent and collaborations highlight his commitment to improving healthcare solutions. His contributions are paving the way for more effective treatments for ocular diseases.